Terms: = Bone cancer AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR AND Diagnosis
105 results:
1. Characteristics, management and outcomes of primary hyperparathyroidism from 2009 to 2021: a single centre report from South Africa.
Govind K; Paruk IM; Motala AA
BMC Endocr Disord; 2024 Apr; 24(1):53. PubMed ID: 38664758
[TBL] [Abstract] [Full Text] [Related]
2. Essential thrombocythemia: 2024 update on diagnosis, risk stratification, and management.
Tefferi A; Vannucchi AM; Barbui T
Am J Hematol; 2024 Apr; 99(4):697-718. PubMed ID: 38269572
[TBL] [Abstract] [Full Text] [Related]
3. diagnosis- and Prognosis-Related Gene Alterations in
Morishita S; Komatsu N
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
[No Abstract] [Full Text] [Related]
4. High molecular risk variants, severe thrombocytopenia and large unstained cells count affect the outcome in primary myelofibrosis.
Kanduła Z; Janowski M; Więckowska B; Paczkowska E; Mroczkowska-Bękarciak A; Sobas M; Lewandowski K
J Appl Genet; 2023 Sep; 64(3):479-491. PubMed ID: 37507589
[TBL] [Abstract] [Full Text] [Related]
5. Comparing Risk for Second Primary cancers After Intensity-Modulated vs 3-Dimensional Conformal Radiation Therapy for Prostate cancer, 2002-2015.
Pithadia KJ; Advani PG; Citrin DE; Bekelman JE; Withrow DR; Berrington de Gonzalez A; Morton LM; Schonfeld SJ
JAMA Oncol; 2023 Aug; 9(8):1119-1123. PubMed ID: 37289449
[TBL] [Abstract] [Full Text] [Related]
6. MEAI: an artificial intelligence platform for predicting distant and lymph node metastases directly from primary breast cancer.
Fan J; Zhang L; Lv T; Liu Y; Sun H; Miao K; Jiang C; Li L; Pan X
J Cancer Res Clin Oncol; 2023 Sep; 149(11):9229-9241. PubMed ID: 37199837
[TBL] [Abstract] [Full Text] [Related]
7. JAK2/STAT5 Pathway Mutation Frequencies in South African BCR/ABL Negative MPN Patients.
Shires KL; Rust AJ; Harryparsad R; Coburn JA; Gopie RE
Hematol Oncol Stem Cell Ther; 2023 Apr; 16(3):291-302. PubMed ID: 37023224
[TBL] [Abstract] [Full Text] [Related]
8. Combination of NeuX and NeuZ can predict neutrophil dysplasia features of myelodysplastic neoplasms in peripheral blood.
Sun P; Li N; Zhang S; Liu S; Zhang H; Yue B
Int J Lab Hematol; 2023 Aug; 45(4):522-527. PubMed ID: 36922282
[TBL] [Abstract] [Full Text] [Related]
9. Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.
Morimoto A; Shioda Y; Kudo K; Kanegane H; Imamura T; Koh K; Kosaka Y; Yuza Y; Nakazawa A; Saito AM; Watanabe T; Nakazawa Y
Int J Hematol; 2023 Jul; 118(1):107-118. PubMed ID: 36871086
[TBL] [Abstract] [Full Text] [Related]
10. Clinical and immunological features of patients with cancer-associated systemic sclerosis: An observational study.
Lopez L; Barnetche T; Galli G; Seneschal J; Blanchard E; Shipley E; Pellegrin JL; Lazaro E; Constans J; Duffau P; Schaeverbeke T; Richez C; Kostine M; Truchetet ME
Joint Bone Spine; 2023 May; 90(3):105555. PubMed ID: 36842760
[TBL] [Abstract] [Full Text] [Related]
11. Giant cell tumor of bone with H3F3B mutation: A case report.
Wu R; Wu X; Weng X; Xiu Y; Xu G; Liu X; Liu X
Medicine (Baltimore); 2023 Feb; 102(7):e32995. PubMed ID: 36800629
[TBL] [Abstract] [Full Text] [Related]
12. A Retrospective Chart Review of 809 Patients with Physician-Diagnosed Essential Thrombocythemia Receiving Cytoreductive Therapy in US Community Oncology Practices.
Yu J; Paranagama D; Hanna B; Tang J; Chojecki A
Acta Haematol; 2023; 146(1):26-36. PubMed ID: 36001945
[TBL] [Abstract] [Full Text] [Related]
13. Impact of molecular profiling on the management of patients with myelofibrosis.
Pastor-Galán I; Martín I; Ferrer B; Hernández-Boluda JC
Cancer Treat Rev; 2022 Sep; 109():102435. PubMed ID: 35839532
[TBL] [Abstract] [Full Text] [Related]
14. [Search for mutations in patients with Philadelphia negative myeloproliferative neoplasms in a public hospital in Chile].
Jaramillo I; Torres V; Leyton L; Navarrete M; Pilleux L
Rev Med Chil; 2022 Jul; 150(7):849-854. PubMed ID: 37906817
[TBL] [Abstract] [Full Text] [Related]
15. How I Diagnose Primary Myelofibrosis.
Prakash S; Orazi A
Am J Clin Pathol; 2022 Apr; 157(4):518-530. PubMed ID: 35238345
[TBL] [Abstract] [Full Text] [Related]
16. Prevalence of mental disorders in patients with cancer compared to matched controls - secondary analysis of two nationally representative surveys.
Vehling S; Mehnert-Theuerkauf A; Philipp R; Härter M; Kraywinkel K; Kuhnert R; Koch U
Acta Oncol; 2022 Jan; 61(1):7-13. PubMed ID: 34731069
[TBL] [Abstract] [Full Text] [Related]
17. Clonal Megakaryocyte Dysplasia with Normal Blood Values Is a Distinct Myeloproliferative Neoplasm.
Barosi G; Rosti V; Massa M; Campanelli R; Villani L; Catarsi P; Carolei A; Abbà C; Lodigiani C; Primignani M; Gregato G; Bertolini F; Magrini U; Gale RP
Acta Haematol; 2022; 145(1):30-37. PubMed ID: 34280924
[TBL] [Abstract] [Full Text] [Related]
18. The value of bone marrow, liver, and spleen imaging in diagnosis, prognostication, and follow-up monitoring of myeloproliferative neoplasms: a systematic review.
Slot S; van de Donk NWCJ; Otten RHJ; Boden BJH; Zijlstra J; Raijmakers PGHM; Zweegman S
Cancer Imaging; 2021 Apr; 21(1):36. PubMed ID: 33879266
[TBL] [Abstract] [Full Text] [Related]
19. Clinical and Molecular Attributes of Patients With BCR/ABL1-negative Myeloproliferative Neoplasms in India: Real-world Data and Challenges.
Singh S; Kaur K; Paul D; Jain K; Singh J; Narang V; Garg B; Sood N; Dhillon B
Clin Lymphoma Myeloma Leuk; 2021 Jun; 21(6):e569-e578. PubMed ID: 33757770
[TBL] [Abstract] [Full Text] [Related]
20. Blood-based genomics of triple-negative breast cancer progression in patients treated with neoadjuvant chemotherapy.
Ortolan E; Appierto V; Silvestri M; Miceli R; Veneroni S; Folli S; Pruneri G; Vingiani A; Belfiore A; Cappelletti V; Vismara M; Dell'Angelo F; De Cecco L; Bianchi GV; de Braud FG; Daidone MG; Di Cosimo S
ESMO Open; 2021 Apr; 6(2):100086. PubMed ID: 33743331
[TBL] [Abstract] [Full Text] [Related]
[Next]
